An aid worker from the Spanish NGO Open Arms touches coronavirus detection test kits at a nursing home in Barcelona, Spain.

An aid worker from the Spanish NGO Open Arms touches coronavirus detection test kits at a nursing home in Barcelona, Spain. Santi Palacios / AP

Coronavirus Roundup: HHS Cancels Celebrities Campaign; FDA Approves First Rapid At-Home COVID-19 Test

There's a lot to keep track of. Here’s today’s list of news updates and stories you may have missed.

Pfizer and BioNTech announced on Wednesday morning that their coronavirus vaccine is 95% effective, which comes a week after it released early results saying the vaccine was over 90% effective. The companies plan to seek emergency use authorization from the Food and Drug Administration “within days.” They are not formally part of “Operation Warp Speed,” but signed a $1.95 billion contract with the Trump administration in July to supply 100 million doses if their vaccine is approved. Here are some of the other recent headlines you might have missed. 

On Tuesday, the Health and Human Services Department inspector general issued a report on HHS’ top management challenges for fiscal 2021, many of which involve the pandemic. These include: mitigating negative health consequences of COVID-19; ensuring transparency and accountability in use of pandemic funds; implementing telehealth and other flexibility; providing access to timely and accurate coronavirus data; coordinating activity among federal, state, tribal and private sector stakeholders; and more. 

HHS abandoned a $15 million contract with Atlas Research to use celebrities in a coronavirus public relations campaign, which was part of a larger, $300 million campaign to “inspire hope” about the pandemic, Politico reported on Tuesday. This campaign has garnered much trepidation from Democratic lawmakers. “Following the outcry, HHS commissioned an internal review, with input from career civil servants, about whether the campaign met public health goals,” said the report. “HHS concluded the Atlas contract should be canceled, but it found the broader awareness campaign could continue.”

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said during an event on Tuesday that he could have been “much more vocal” about the need for mass testing earlier on in the pandemic. He also said that President-elect Joe Biden has a “considerable, in fact, if not profound” grasp of and appreciation for science, though he said the two have not spoken since Biden left office four years ago, Stat News reported

NIAID’s advisory committee on the coronavirus will have a closed meeting on December 11 to “review and evaluate grant applications,” according to a notice posted in the Federal Register on Wednesday. 

Biden’s coronavirus task force said on Tuesday that not being able to work with the Trump administration is hindering their pandemic preparations. “The transition team is unable to consult with federal health officials or access real-time data on available hospital beds, the status of the national strategic stockpile and therapeutics, among other things,” Politico reported. “For now, they said that's forcing them to rely on piecemeal data from state and local officials and public sources like the Covid Tracking Project.”

On Tuesday, the FDA issued emergency use authorization for the first at-home coronavirus test that provides quick results. “This new testing option is an important diagnostic advancement to address the pandemic and reduce the public burden of disease transmission,” said FDA Commissioner Dr. Stephen Hahn. 

The Census Bureau launched the third phase of its survey to measure how small businesses are faring during the pandemic. The first results will come out on Thursday and then will be released weekly. “The responses from the prior phases have been enormously valuable in gaining a deeper understanding about how small businesses are faring during the pandemic,” said the Census Bureau on Tuesday. “Given the duration of the pandemic, there is a continued need for this information to help inform policy.”

On Tuesday, the Justice Department IG issued its second interim report about DoJ’s Office of Justice Programs' use of CARES Act funds, which received 84% of the department's total funds. “As of August 22, 2020, OJP’s Bureau of Justice Assistance had awarded 99.7% of the $850 million received under the CARES Act, and that most recipient spending we reviewed appeared allowable under the terms and conditions of the grant award,” said the IG. “When concerns were identified related to unallowable spending or a lack of adherence to internal policies and procedures, OJP acted quickly to remedy the issues, as discussed in detail [in the report].”

Jeff Tribiano, deputy commissioner at the Internal Revenue Service, outlined on Tuesday how the IRS was able to have a successful tax filing season amid the pandemic and distributing stimulus checks authorized in the CARES Act. “This has been an unprecedented year unlike any we’ve ever seen. And with COVID-19 continuing and another major tax season approaching in 2021, the IRS still has more work to do,” he said. “But as I’ve seen throughout my career of service to the nation, times like this bring out the best in people. As the IRS has throughout its history, our employees deliver for the nation in times of crisis.” 

Today’s GovExec Daily podcast episode is about technology priorities for the incoming Biden administration.  

Help us understand the situation better. Are you a federal employee, contractor or military member with information, concerns, etc. about how your agency is handling the coronavirus? Email us at newstips@govexec.com.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.